Article info
PDFA difficult case
Conus medullaris syndrome as a presenting feature of MOG-associated disease
- Correspondence to Dr Memoona Nasir, Queen's Hospital Department of Neurology, Romford, London, UK; memoona.nasir{at}nhs.net
Citation
Conus medullaris syndrome as a presenting feature of MOG-associated disease
Publication history
- Accepted December 11, 2022
- First published January 13, 2023.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease
- Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations
- Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis
- Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein
- A practical approach to the diagnosis of spinal cord lesions
- Optic neuritis with potential for poor outcome
- CNS inflammatory demyelinating disorders: MS, NMOSD and MOG antibody associated disease
- Clinical characteristics and prognosis of myelin oligodendrocyte glycoprotein antibody-seropositive paediatric optic neuritis in China
- Neuromyelitis optica spectrum disorder presenting as rhomboencephalitis
- CSF levels of glutamine synthetase and GFAP to explore astrocytic damage in seronegative NMOSD